Jamie Sulley
About Jamie Sulley
Jamie Sulley Leadership in Global Regulatory Affairs
Jamie Sulley currently holds the position of Senior Vice President — Global Regulatory Affairs and Technology Operations. With over three decades of experience in the biotech and pharmaceutical industry, Sulley plays a pivotal role in overseeing regulatory compliance and technological advancements. His extensive background signifies a deep expertise in managing global regulatory frameworks and operational technology, ensuring the companies he works for comply with international guidelines and standards.
Jamie Sulley Professional Experience in Biotech and Pharma
Jamie Sulley boasts 32 years of diverse experience in the biotech and pharmaceutical sectors. His career includes prestigious roles such as President and Board Member of Tamir Biotechnology, which was acquired by Orgenesis, and Chief Operating Officer of Tensys Medical, which was later acquired by Shanshi. Sulley also held the position of General Manager for Pharmalink Consulting, now part of Genpact. Previously, he was President of TCSI and JASA, demonstrating his extensive leadership and governance capabilities across various organizations.
Jamie Sulley Contributions to Drug Development Programs
Jamie Sulley has significantly contributed to drug development programs, guiding them from the proof of concept stage through to global commercialization. His experience spans New Chemical Entity (NCE), 505(b)(1), and 505(b)(2) product pathways, encompassing development processes for small molecules, biologics, and combination products. His strategic leadership and scientific insight have been crucial in bringing new medical solutions to market, enhancing patient care worldwide.
Jamie Sulley Educational Background and Expertise
Jamie Sulley holds an impressive academic portfolio with a BS and PhD in Chemistry, coupled with a Masters in Public Health from the University of Liverpool. This solid educational foundation supports his extensive professional experience, providing him with the analytical and technical skills necessary for high-level decision-making in the biotechnology and pharmaceutical industries. His expertise is further validated by his accreditation as an FDA reviewer, attesting to his proficiency in regulatory affairs.